16-1079082-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001172560.3(SSTR5):c.214A>G(p.Lys72Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000822 in 1,460,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001172560.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249586Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135544
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460330Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 726472
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.214A>G (p.K72E) alteration is located in exon 1 (coding exon 1) of the SSTR5 gene. This alteration results from a A to G substitution at nucleotide position 214, causing the lysine (K) at amino acid position 72 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at